Chau-Ting Yeh

13PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 11, 2025
GALNT14 Genetic Variants Harbor Differential Prognostic Values Linking to Distinct Macrophage Cell Types in Hepatocellular Carcinoma.

Yu-De Chu, Pei-Huan Ho, Wei-Ting Chen

|Oct 10, 2023
Aldolase B-driven lactagenesis and CEACAM6 activation promote cell renewal and chemoresistance in colorectal cancer through the Warburg effect.

Yu-De Chu, Li-Chun Cheng, Siew-Na Lim

|Nov 14, 2022
GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells.

Yu-De Chu, Tan-Chi Fan, Ming-Wei Lai

|Jan 04, 2022
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial.

Wei-Ting Chen, Shi-Ming Lin, Wei-Chen Lee

|Jun 18, 2021
LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing.

Yang-Hsiang Lin, Meng-Han Wu, Yi-Chung Liu

|Aug 31, 2019
Decreasing seroprevalence of anti-hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019.

Kuan-Chieh Lee, Chih-Lang Lin, Chao-Wei Hsu

Pageof 3

Frequent Collaborators

1 joint publications

Yu-Chiau Shyu

1 joint publications

Yang-Hsiang Lin

1 joint publications

Kwang-Huei Lin

1 joint publications

Yu-De Chu